{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:45:49Z","timestamp":1792691149793,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["638965"],"award-info":[{"award-number":["638965"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.xphs.2021.09.009","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T20:30:42Z","timestamp":1631305842000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of Cellular Monolayers and an Artificial Membrane as Absorptive Membranes in the in vitro Lipolysis-permeation Assay"],"prefix":"10.1016","volume":"111","author":[{"given":"Janneke","family":"Keemink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8196-608X","authenticated-orcid":false,"given":"Oliver J.","family":"Hedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5908-9535","authenticated-orcid":false,"given":"Madlen","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-2612","authenticated-orcid":false,"given":"Christel A.S.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2021.09.009_bib0001","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biochi.2015.11.016","article-title":"Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs","volume":"125","author":"Carri\u00e8re","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.xphs.2021.09.009_bib0002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.addr.2021.02.001","article-title":"Current challenges and future perspectives in oral absorption research: an opinion of the UNGAP network","volume":"171","author":"Vinarov","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"10.1016\/j.xphs.2021.09.009_bib0003","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1080\/10717544.2016.1214990","article-title":"Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view","volume":"23","author":"Chatterjee","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2021.09.009_bib0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50years of oral lipid-based formulations: provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.xphs.2021.09.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02833-9","article-title":"Suitability of artificial membranes in lipolysis-permeation assays of oral lipid-based formulations","volume":"37","author":"Hedge","year":"2020","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2021.09.009_bib0006","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/mp300331z","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion","volume":"9","author":"Williams","year":"2012","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2021.09.009_bib0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.apsb.2014.09.001","article-title":"Pharmacokinetic aspects and in vitro\u2013in vivo correlation potential for lipid-based formulations","volume":"4","author":"Kollipara","year":"2014","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.xphs.2021.09.009_bib0008","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1208\/s12248-014-9589-4","article-title":"In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate","volume":"16","author":"Thomas","year":"2014","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.xphs.2021.09.009_bib0009","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s11095-015-1843-7","article-title":"A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations","volume":"33","author":"Crum","year":"2016","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.09.009_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2007.01.017","article-title":"The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats","volume":"67","author":"Dahan","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.09.009_bib0011","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.xphs.2020.08.026","article-title":"Predicting oral absorption of fenofibrate in lipid-based drug delivery systems by combining in vitro lipolysis with the mucus-PVPA permeability model","volume":"110","author":"Falavigna","year":"2021","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2021.09.009_bib0012","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics13040489","article-title":"Estimating the oral absorption from self-nanoemulsifying drug delivery systems using an in vitro lipolysis-permeation method","volume":"13","author":"Klitgaard","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0013","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s13346-017-0383-6","article-title":"Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems","volume":"8","author":"Sadhukha","year":"2018","journal-title":"Drug Deliv Transl Res"},{"issue":"12","key":"10.1016\/j.xphs.2021.09.009_bib0014","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1007\/s11095-014-1432-1","article-title":"Biopharmaceutical modeling of drug supersaturation during lipid-based formulation digestion considering an absorption sink","volume":"31","author":"Stillhart","year":"2014","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2021.09.009_bib0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.molpharmaceut.8b00811","article-title":"A lipolysis-permeation setup for simultaneous study of digestion and absorption in vitro","volume":"16","author":"Keemink","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2021.09.009_bib0016","article-title":"In vitro intestinal drug disposition device","author":"Bergstr\u00f6m","year":"2021","journal-title":"Patent EP 3678638 B1"},{"key":"10.1016\/j.xphs.2021.09.009_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2019.04.038","article-title":"Effect of lipids on absorption of carvedilol in dogs: is coadministration of lipids as efficient as a lipid-based formulation?","volume":"304","author":"Alsk\u00e4r","year":"2019","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/j.xphs.2021.09.009_bib0018","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat Protoc"},{"issue":"5","key":"10.1016\/j.xphs.2021.09.009_bib0019","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1568026013394886","article-title":"Strategies for absorption screening in drug discovery and development","volume":"1","author":"Bohets","year":"2001","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0020","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-3549(15)00171-9","article-title":"Complete knockout of endogenous Mdr1 (Abcb1) in MDCK cells by CRISPR-Cas9","volume":"105","author":"Simoff","year":"2016","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2021.09.009_bib0021","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.10.016","article-title":"Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate","volume":"86","author":"Griffin","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2021.09.009_bib0022","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2019.01.008","article-title":"Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs","volume":"142","author":"Vithani","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0023","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2021.09.009_bib0024","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/jps.24067","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, Part 4: Proposing a new lipid formulation performance classification system","volume":"103","author":"Williams","year":"2014","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2021.09.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-017-2327-8","article-title":"Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations","volume":"35","author":"Keemink","year":"2018","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2021.09.009_bib0026","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/mp200460u","article-title":"The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations","volume":"9","author":"Miller","year":"2012","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2021.09.009_bib0027","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/acs.molpharmaceut.1c00015","article-title":"Digestion of lipid-based formulations not only mediates changes to absorption of poorly soluble drugs due to differences in solubilization but also reflects changes to thermodynamic activity and permeability","volume":"18","author":"Tanaka","year":"2021","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2021.09.009_bib0028","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acs.molpharmaceut.9b00406","article-title":"Prediction of bioequivalence and food effect using flux- and solubility-based methods","volume":"16","author":"Borb\u00e1s","year":"2019","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2021.09.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2440-3","article-title":"Ranking itraconazole formulations based on the flux through artificial lipophilic membrane","volume":"35","author":"Tsinman","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2021.09.009_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejpb.2020.01.010","article-title":"An in vitro dissolution\u2013digestion\u2013permeation assay for the study of advanced drug delivery systems","volume":"149","author":"Alvebratt","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"issue":"16","key":"10.1016\/j.xphs.2021.09.009_bib0031","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4155\/fmc.11.149","article-title":"Drug-permeability and transporter assays in Caco-2 and MDCK cell lines","volume":"3","author":"Volpe","year":"2011","journal-title":"Future Med Chem"},{"issue":"9","key":"10.1016\/j.xphs.2021.09.009_bib0032","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.xphs.2017.04.018","article-title":"A CRISPR-Cas9 generated MDCK cell line expressing human MDR1 without endogenous canine MDR1 (cABCB1): an improved tool for drug efflux studies","volume":"106","author":"Karlgren","year":"2017","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0033","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/bdd.2025","article-title":"Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue","volume":"38","author":"Br\u00fcck","year":"2017","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2021.09.009_bib0034","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby Canine Kidney) cells: a tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2010.06.008","article-title":"Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2)","volume":"76","author":"Hanke","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2021.09.009_bib0036","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2019.03.010","article-title":"Cytotoxicity and permeability enhancement of Capmul\u00aeMCM in nanoemulsion formulation","volume":"561","author":"Bunchongprasert","year":"2019","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2021.09.009_bib0037","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1124\/dmd.118.085092","article-title":"Carboxylesterase 2 and intestine transporters contribute to the low bioavailability of Allisartan, a prodrug of Exp3174 for hypertension treatment in humans","volume":"47","author":"Li","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.xphs.2021.09.009_bib0038","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1124\/dmd.105.004226","article-title":"Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption","volume":"33","author":"Imai","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0039","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.xphs.2015.10.030","article-title":"The proteome of filter-grown Caco-2 cells with a focus on proteins involved in drug disposition","volume":"105","author":"\u00d6lander","year":"2016","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.xphs.2021.09.009_bib0041","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.xphs.2021.09.009_bib0042","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jmb.2005.07.016","article-title":"Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by Benzil","volume":"352","author":"Fleming","year":"2005","journal-title":"J Mol Biol"},{"issue":"4","key":"10.1016\/j.xphs.2021.09.009_bib0043","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/pharmaceutics13040459","article-title":"Oligonucleotide delivery across the Caco-2 monolayer: the design and evaluation of self-emulsifying drug delivery systems (SEDDS)","volume":"13","author":"Kubackova","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.xphs.2021.09.009_bib0044","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.xphs.2019.01.032","article-title":"Simultaneous analysis of dissolution and permeation profiles of nanosized and microsized formulations of indomethacin using the in vitro dissolution absorption system 2","volume":"108","author":"Li","year":"2019","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI104909","article-title":"The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption*","volume":"43","author":"Hofmann","year":"1964","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.xphs.2021.09.009_bib0046","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI111809","article-title":"Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction","volume":"75","author":"Liddle","year":"1985","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.xphs.2021.09.009_bib0047","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1021\/mp300331z","article-title":"Toward the establishment of standardized in Vitro tests for lipid-based formulations. 2. the effect of bile salt concentration and drug loading on the performance of Type I, II, IIIA, IIIB, and IV formulations during in Vitro digestion","volume":"9","author":"Williams","year":"2012","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2021.09.009_bib0048","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/eci.12161","article-title":"New insights into the molecular mechanism of intestinal fatty acid absorption","volume":"43","author":"Wang","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.xphs.2021.09.009_bib0049","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0163-7827(03)00050-X","article-title":"The digestion of dietary triacylglycerols","volume":"43","author":"Mu","year":"2004","journal-title":"Prog Lipid Res"},{"issue":"6","key":"10.1016\/j.xphs.2021.09.009_bib0050","doi-asserted-by":"crossref","first-page":"e12018","DOI":"10.14814\/phy2.12018","article-title":"Chylomicrons produced by Caco-2 cells contained ApoB-48 with diameter of 80-200nm","volume":"2","author":"Nauli","year":"2014","journal-title":"Physiol Rep"},{"issue":"3","key":"10.1016\/j.xphs.2021.09.009_bib0051","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1388-1981(99)00085-2","article-title":"Caco-2 cells and human fetal colon: a comparative analysis of their lipid transport","volume":"1439","author":"Levy","year":"1999","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:36:51Z","timestamp":1758361011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921004780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0022354921004780"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.09.009","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Cellular Monolayers and an Artificial Membrane as Absorptive Membranes in the in vitro Lipolysis-permeation Assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}